AstraZeneca PLC (AZN)
192.13
+2.23
(+1.17%)
USD |
NYSE |
Mar 16, 16:00
192.13
0.00 (0.00%)
After-Hours: 20:00
AstraZeneca Shareholders Equity (Quarterly) : 48.67B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| GSK Plc | 22.03B |
| Mereo BioPharma Group Plc | 46.60M |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
| Biodexa Pharmaceuticals Plc | -- |
| Moderna, Inc. | 8.65B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.07B |
| Total Liabilities (Quarterly) | 65.30B |
| Debt to Equity Ratio | 0.6087 |
| Current Ratio | 0.9381 |
| Net Debt Paydown Yield | 0.14% |